Bellerophon Therapeutics, Inc. announced on April 19, 2023, Nicholas Laccona, Principal Financial and Accounting Officer of the company, notified the Company of his intent to resign as Principal Financial and Accounting Officer and from all other positions held with the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.051 USD | 0.00% | +2.00% | +37.84% |
May. 02 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 25 | North American Morning Briefing : More Tech -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
+37.84% | 624K | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- BLPH Stock
- News Bellerophon Therapeutics, Inc.
- Bellerophon Therapeutics, Inc. Announces Resignation of Nicholas Laccona as Principal Financial and Accounting Officer